We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New U.S. Trade Agreements May Block Generic Access to Foreign Markets
New U.S. Trade Agreements May Block Generic Access to Foreign Markets
April 12, 2007
Language in newly signed free trade agreements (FTAs) covering data exclusivity and patent extension could delay generic drug entry in foreign markets where access to low-cost medicines is highly needed, a bipartisan group of lawmakers contends.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor